|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.270 INR | +2.43% |
|
-6.65% | -35.17% |
| Market Cap | 1.73B 17.99M 15.72M 14.51M 13.37M 25.2M 25.76M 173M 68.19M 848M 67.55M 66.07M 2.92B | P/E 2024 |
26x | P/E 2025 | 15.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.46B 15.13M 13.23M 12.2M 11.25M 21.2M 21.67M 146M 57.38M 714M 56.84M 55.59M 2.46B | EV / Sales 2024 |
3.67x | EV / Sales 2025 | 1.79x |
| Free-Float |
65.03% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.43% | ||
| 1 week | -6.65% | ||
| Current month | -13.53% | ||
| 1 month | -11.63% | ||
| 3 months | -10.00% | ||
| 6 months | -28.53% | ||
| Current year | -35.17% |
| 1 week | 8.95 | 9.84 | |
| 1 month | 8.65 | 12.5 | |
| Current year | 7.05 | 14.77 | |
| 1 year | 7.05 | 17.25 | |
| 3 years | 6.15 | 29 | |
| 5 years | 4.81 | 29 | |
| 10 years | 1.32 | 29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Arihant Baid
CEO | Chief Executive Officer | 40 | 17/05/2012 |
| Director of Finance/CFO | - | 11/11/2024 | |
| Compliance Officer | 62 | 19/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Arihant Baid
CHM | Chairman | 40 | - |
| Director/Board Member | - | 20/12/2020 | |
| Director/Board Member | - | 20/12/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.43% | -6.65% | -32.24% | +40.24% | 23.39M | ||
| +0.85% | -0.80% | +52.79% | +159.97% | 1,051B | ||
| +1.23% | -1.53% | +54.58% | +59.41% | 609B | ||
| +0.04% | +2.58% | +34.47% | +84.84% | 450B | ||
| +0.78% | -0.71% | +29.28% | +23.25% | 330B | ||
| +1.41% | +0.58% | +35.44% | +40.53% | 284B | ||
| -0.27% | -1.87% | +22.34% | +19.92% | 263B | ||
| -1.76% | +2.37% | -20.43% | -38.01% | 223B | ||
| -1.42% | +0.80% | +24.27% | +57.85% | 198B | ||
| -1.48% | +3.43% | +24.08% | +70.06% | 167B | ||
| Average | +0.18% | -0.18% | +22.46% | +51.81% | 357.51B | |
| Weighted average by Cap. | +0.37% | +0.02% | +37.51% | +78.76% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 867M 9M 7.87M 7.26M 6.69M 12.62M 12.9M 86.79M 34.14M 425M 33.82M 33.07M 1.46B | 1.38B 14.32M 12.51M 11.55M 10.64M 20.06M 20.51M 138M 54.29M 675M 53.78M 52.6M 2.33B |
| Net income | 132M 1.37M 1.2M 1.1M 1.02M 1.92M 1.96M 13.19M 5.19M 64.53M 5.14M 5.03M 222M | 181M 1.88M 1.64M 1.52M 1.4M 2.64M 2.7M 18.14M 7.13M 88.76M 7.07M 6.91M 306M |
| Net Debt | -413M -4.29M -3.75M -3.46M -3.19M -6.01M -6.14M -41.33M -16.26M -202M -16.1M -15.75M -696M | -275M -2.85M -2.49M -2.3M -2.12M -4M -4.09M -27.5M -10.82M -135M -10.72M -10.48M -463M |
Employees
115
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | ₹9.270 | +2.43% | 416,150 |
| 16/07/26 | ₹9.050 | -2.48% | 384,463 |
| 15/07/26 | ₹9.280 | -2.62% | 358,404 |
| 14/07/26 | ₹9.530 | -2.26% | 228,345 |
| 13/07/26 | ₹9.750 | -1.81% | 833,904 |
- Stock Market
- Stocks
- GENNEX6 Stock
Select your edition
All financial news and data tailored to specific country editions
















